Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/OCF ratio is N/A as of 2026-10-06T17:36:16.009Z.
Calculation as of: 2026-10-06T17:36:16.009Z.
Quote observation: 2026-10-06T17:29:32.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 12cea9f103536ce45d7cd9f5ad4e572cb47010be1e9ba78d50bf2d4cf37a5898
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
N/A
Market Cap
$45.20M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$44.19M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$43.73M
Price/OCF Ratio
N/A
TTM Avg
9.67
3Y Avg
15.53
5Y Avg
36.04
Market Cap
$43.34M
Price/OCF Ratio
8.30
TTM Avg
102.83
3Y Avg
129.05
5Y Avg
129.05
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DarioHealth Corp. (DRIO) | $44.82M | N/A | N/A | N/A | N/A |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $45.20M | N/A | N/A | N/A | N/A |
| CVRx, Inc. (CVRX)vs › | $44.45M | N/A | N/A | N/A | N/A |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $44.19M | N/A | N/A | N/A | N/A |
| BioStem Technologies, Inc. (BSEM)vs › | $43.73M | N/A | 9.67 | 15.53 | 36.04 |
| Nano-X Imaging Ltd. (NNOX)vs › | $43.67M | N/A | N/A | N/A | N/A |
| Instil Bio, Inc. (TIL)vs › | $46.25M | N/A | N/A | N/A | N/A |
| SANUWAVE Health Inc. (SNWV)vs › | $43.34M | 8.30 | 102.83 | 129.05 | 129.05 |
| Precipio, Inc. (PRPO)vs › | $41.85M | 38.04 | 48.39 | 39.24 | 39.24 |
| Precision Optics Corporation, Inc. (POCI)vs › | $48.16M | N/A | 73.59 | 628.92 | 487.62 |
P/OCF Ratio
N/A
P/FCF Ratio
N/A
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
